Cassava Sciences: A Top Debt-Free Stock Pickby Lilu Anderson 18.08.2024Cassava Sciences stands out as a leading debt-free stock with significant upside potential, offering strong financial health.
Vestas Wind Systems Shares Surge Post Q2 Resultsby Mark Eisenberg 18.08.2024Vestas' Q2 results meet expectations; strong order intake and pricing boost outlook for second half of 2023.
Dollar Dips as Inflation Cools, Euro Risesby Mark Eisenberg 18.08.2024US inflation cools, boosting euro; markets expect Fed rate cuts. Sterling and Kiwi slip amid global economic shifts.
Tecan Revises 2024 Outlook Amid Market Challengesby Mark Eisenberg 18.08.2024Tecan reports lower H1 2024 sales, revises full-year outlook due to biopharma sector weakness and market challenges in China.
Spirit Aero CEO’s $28.5M Golden Parachute Dealby Mark Eisenberg 15.08.2024CEO Patrick Shanahan to receive $28.5M after Spirit merger with Boeing. Includes cash, stock, and perks.
Genmab Reports 36% Revenue Growth in H1 2024by Mark Eisenberg 15.08.2024Genmab's H1 2024 results show 36% revenue growth; DARZALEX sales surge, and strategic acquisition of ProfoundBio boosts future potential.
RYVYL Inc. Q2 2024: International Growth Surgeby Mark Eisenberg 15.08.2024RYVYL Inc. reports 134% international revenue growth in Q2 2024, offsetting North American decline.
Global Stocks Rise on Fed Rate Cut Hopesby Mark Eisenberg 15.08.2024Stock markets gain globally as investors anticipate a Federal Reserve interest rate cut amid positive economic indicators.
Glanbia Sees Strong H1 2024 Growth, EPS Up 12.4%by Mark Eisenberg 15.08.2024Glanbia reports 12.4% EPS growth in H1 2024 amid strong demand and strategic acquisitions.
AI Helps ALS Patients Communicate Uniquelyby Lilu Anderson 15.08.2024Brain implants and AI voice technology enable ALS patients to communicate effectively.